Posted by Michael Wonder on 28 Mar 2026
The potential loophole in Trump’s plan to get other countries to pay more for drugs
24 March 2026 - Comments from a top health official point to a big issue.
Comments from a top Trump Administration health official add to signs of a major flaw in the president’s most favoured nation drug pricing plans.
The official, Chris Klomp, said last week that the most favoured nation deals aim to increase the prices of new drugs in peer countries, not lower US prices. But by the time companies launch those drugs abroad, the deals might be over and Trump might be out of office.
